DUBLIN--(BUSINESS WIRE)--The "Stem Cell Technologies and Applications Market Report 2023-2033" has been added to ResearchAndMarkets.com's offering. World revenue for the Stem Cell Technologies and ...

Stem cell therapy is redeeming itself after striking failures. With therapies well into clinical trials, successes are accumulating. Among the success stories is the first mesenchymal stem cell (MSC) ...

Multipotent dental stem cells can give rise to various cell types and show potential for treating injuries, diabetes, and heart disease in early clinical trials.

Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...

To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have ...

Editor’s Note: Hans Keirstead has started six high-tech health companies, including Aivita Biomedical to develop stem cell applications and Immunis Inc. to help people improve their immunity with a ...

DUBLIN--(BUSINESS WIRE)--The "Cord Blood Stem Cells - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global cord blood stem cells market is estimated to be ...

Stem cell therapy holds great promise for various diseases. In fact, in what many are hailing as a medical milestone, European researchers have successfully transplanted a trachea built from a patient ...

Stem cells are special in the way they can keep on replicating, and turn themselves into many other types of cell. Now scientists have discovered how their superpowers get a remarkable boost when they ...